The most recent listing of current clinical trials for brain cancer appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Brain
| Protocol ID |
|
Title |
|
| RTOG 0227 |
|
Phase I/II Study of Pre-Irradiation Chemotherapy with Methotrexate Rituximab, and Temozolomide and Post-Irradiation Temozolomide for Primary Central Nervous System Lymphoma
Keywords: central nervous system lymphoma |
|
| RTOG 0513 |
|
A phase I/II Trial of Temozomide, Motexafin Gadolinum, and 60 GY Fractionated Radition for Newly Diagnosed Supratentorial Glioblastoma Multiforme
Keywords: radion for newly diagnosed Supratentorial Glioblastoma Multiforme |
|
| RTOG 0320 |
|
Phase III trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone versus with Temozolomide or Gefitinib in Patients with Non-Small Cell Lung Cancer and 1-*3 Brain Metastases
Keywords: non-small cell lung cancer and 1-*3 brain metastases |
|
| RTOG 0424 |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy for High Risk Low-Grade Gliomas
Keywords: high risk low-grade gliomas |
|
| RTOG 0525 |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma
Keywords: newly diagnosed glioblastoma |
|
| RTOG 0625 |
|
A Randomized Phase II Trial of Bevacizumab with Ironotecan or Bevacizumab with Temozolomide in Recurrent Glioblastoma
Keywords: recurrent glioblastoma |
|
| RTOG 0627 |
|
Phase II Trial of Dasatinib in Patients with Recurrent Glioblastoma Multiform
Keywords: recurrent Glioblastoma Multiform |
|
| Industry-brain |
|
Avastin and Temozolomide following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme: a Phase II Study
Keywords: Newly Diagnosed Glioblastoma Multiforme |